{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0378-6961",
      "generic_name": "Glatiramer",
      "labeler_name": "Mylan Pharmaceuticals Inc.",
      "brand_name": "Glatiramer Acetate",
      "active_ingredients": [
        {
          "name": "GLATIRAMER ACETATE",
          "strength": "40 mg/mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0378-6961-12",
          "description": "12 BLISTER PACK in 1 CARTON (0378-6961-12)  / 1 SYRINGE in 1 BLISTER PACK (0378-6961-32)  / 1 mL in 1 SYRINGE",
          "marketing_start_date": "20171004",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Mylan Pharmaceuticals Inc."
        ],
        "rxcui": [
          "1487361"
        ],
        "spl_set_id": [
          "456a34c7-8511-4000-99a7-ad8f8de6d35e"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "5M691HL4BO"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "INJECTION, SOLUTION",
      "spl_id": "f5070abd-2219-47fa-8ff2-c0b147ea3eb7",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "SUBCUTANEOUS"
      ],
      "marketing_start_date": "20171004",
      "product_id": "0378-6961_f5070abd-2219-47fa-8ff2-c0b147ea3eb7",
      "application_number": "ANDA206936",
      "brand_name_base": "Glatiramer Acetate"
    }
  ]
}